These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29845296)

  • 1. Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Cui X; Wang G; Shen W; Huang Z; He H; Cui L
    Oncol Rep; 2018 Aug; 40(2):932-942. PubMed ID: 29845296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylase kinase β affects colorectal cancer cell growth and represents a novel prognostic biomarker.
    Wang G; Shen W; Liu CY; Liu Y; Wu T; Cui X; Yu T; Zhu Y; Song J; Du P; Cui L
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):971-980. PubMed ID: 28275865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LOXL2 reduces 5-FU sensitivity through the Hedgehog/BCL2 signaling pathway in colorectal cancer.
    Qiu Z; Qiu S; Mao W; Lin W; Peng Q; Chang H
    Exp Biol Med (Maywood); 2023 Mar; 248(6):457-468. PubMed ID: 36573458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma.
    Xu J; Li D; Li X; Liu Z; Li T; Jiang P; He Q; Tian F; Gao Y; Wang D; Wang S
    Dig Liver Dis; 2014 Aug; 46(8):750-7. PubMed ID: 24794791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo.
    Xu W; Sheng Y; Guo Y; Huang Z; Huang Y; Wen D; Liu CY; Cui L; Yang Y; Du P
    J Cell Physiol; 2019 Aug; 234(10):18466-18479. PubMed ID: 30895618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
    Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
    Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of abnormal matrix collagen remodeling in colorectal cancer based on histologic and bioinformatics analysis.
    Liang Y; Lv Z; Huang G; Qin J; Li H; Nong F; Wen B
    Oncol Rep; 2020 Oct; 44(4):1671-1685. PubMed ID: 32945508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.
    Yan X; Shan Z; Yan L; Zhu Q; Liu L; Xu B; Liu S; Jin Z; Gao Y
    Oncotarget; 2016 Apr; 7(15):19680-92. PubMed ID: 26967242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
    Brekhman V; Lugassie J; Zaffryar-Eilot S; Sabo E; Kessler O; Smith V; Golding H; Neufeld G
    FASEB J; 2011 Jan; 25(1):55-65. PubMed ID: 20802105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
    Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
    Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.
    Hollosi P; Yakushiji JK; Fong KS; Csiszar K; Fong SF
    Int J Cancer; 2009 Jul; 125(2):318-27. PubMed ID: 19330836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
    Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
    BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.